
ResMed (RMD) Stock Forecast & Price Target
ResMed (RMD) Analyst Ratings
Bulls say
ResMed is benefiting from a growing market for respiratory care devices due to an aging population and increasing prevalence of obesity. The company's recent focus on digital health and data collection sets it apart from competitors. While some segments may have underperformed, cost-cutting efforts and strong margin performance have contributed to solid financial results and increasing guidance for the future.
Bears say
ResMed is facing potential risks with the utilization of its CPAP technology and potential competition from GLP-1 therapeutics, potentially impacting revenue and market share. Despite these risks, the company may continue to gain market share and have a stronger financial performance from recent acquisitions, leading to a higher valuation. However, with an outlook of increased competition and potential disruptions, there may be limited upside potential for the company's stock.
This aggregate rating is based on analysts' research of ResMed and is not a guaranteed prediction by Public.com or investment advice.
ResMed (RMD) Analyst Forecast & Price Prediction
Start investing in ResMed (RMD)
Order type
Buy in
Order amount
Est. shares
0 shares